China Universal Asset Management »

Castle Biosciences shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $117k 5.3k 22.15
2023-12-31 $67k 3.1k 21.58
2023-09-30 $12k 689 16.89
2023-06-30 $4.8k 350 13.72
2023-03-31 $8.2k 360 22.72
2022-12-31 $6.3k 268 23.54
2022-09-30 $6.0k 246 24.39

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Castle Biosciences

BlackRock
Daniel D. Thurber
Granahan Investment Management
Principal Financial Group
Vanguard Group
Bellevue Group
Portolan Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Soleus Capital Management
Citadel Advisors
Morgan Stanley
Geode Capital Management
Palisade Capital Management
Kornitzer Capital Management

View all funds holding Castle Biosciences